Top Markets
Coin of the day
SD BioSensor, Inc SD BioSensor, Inc

SD BioSensor, Inc

137310
Rang in Aktien #13260
SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced... SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced point-of-care testing solutions from its base in South Korea. The company's diverse product portfolio features the STANDARD Q rapid diagnostic platform, offering quick results for various parameters including COVID-19. For laboratory settings, they provide the STANDARD F, a multi-parametric, random-access fluorescence immunoassay system, and the STANDARD E, an ELISA-based solution ideal for extensive screening programs. Their STANDARD M system brings molecular diagnostics closer to the patient, comprising analyzers, assay menus, qPCR reagents, and nucleic acid extraction kits. Furthermore, the procell Dx range focuses on diagnosing infectious diseases such as tuberculosis and SARS-CoV-2, alongside assessing immune status through interferon-gamma release assays. Blood glucose meters also form part of their offerings. Founded in 2010, SD BioSensor is headquartered in Suwon.
Aktienkurs
$4.23
Marktkapitalisierung
$506.22M
Veränderung (1 Tag)
-2.86%
Veränderung (1 Jahr)
-41.34%
Land
KR
Handel SD BioSensor, Inc (137310)

Kategorie

Aktien-Split-Historie für SD BioSensor, Inc (137310)
Die Aktie SD BioSensor, Inc (Symbol: 137310) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 31, 2026 statt.
Eine 137310-Aktie, die vor dem Aug 31, 2026 gekauft wurde, entspricht heute 0 137310-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH